genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
News
Regenerative Medicine/Tissue Engineering
Researchers Pinpoint the Workings behind Liver Regeneration
OMICs
New Bone Cell Type Identified, Could Point to Drug Targets for…
OMICs
Large-Scale Biobank Study Links Primary Cilium to Diabetes, Kidney Disease, and…
GWAS
Genes Linked to Coronary Artery Disease Risk Act through the Liver
Drug Discovery
Evolved Proteases Selectively Cleave Target Sequences, Unlock Potential of “Proteome Editing”
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Regenerative Medicine/Tissue Engineering
Researchers Pinpoint the Workings behind Liver Regeneration
OMICs
New Bone Cell Type Identified, Could Point to Drug Targets for…
OMICs
Large-Scale Biobank Study Links Primary Cilium to Diabetes, Kidney Disease, and…
GWAS
Genes Linked to Coronary Artery Disease Risk Act through the Liver
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Roche
Roche
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Roche
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Roche
Roche and Blueprint Medicines Launch Up-to-$1.7B Partnership to Develop Cancer Drug Pralsetinib
Roche
Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir vs. Severe COVID-19
Roche
Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment
Roche
Declaring National Emergency, Trump Vows Accelerated COVID-19 Testing
Roche
Assessing Coronavirus Impact on Wall Street
Roche
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Roche
Illumina Unveils New Sequencing Systems, Roche Clinical Dx Collaboration
Roche
Roche Buys Ex-U.S. Rights to Sarepta DMD Gene Therapy Candidate SRP-9001...
Roche
Roche to Expand Fibrotic Disease Pipeline with Up-to-$1.4B Promedior Acquisition
Roche
Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration
Roche
Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary...
Roche
Roche Extends Offer for Spark Therapeutics a Second Time, as Shareholders...
Roche
FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer
Roche
Roche-Licensed Rare Disease Drug at Center of Ipsen’s Up-to-$1.3B Clementia Acquisition
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
